Everolimus for advanced, progressive, nonfunctional neuroendocrine tumors (NET) of the gastrointestinal (GI) tract: efficacy and safety from a RADIANT-4 subgroup analysis.
Singh, S Carnaghi, C Buzzoni, R Raderer, M Lahner, H Valle, Juan W Voi, M Pacaud, L Lincy, J Okita, N
Singh, S
Carnaghi, C
Buzzoni, R
Raderer, M
Lahner, H
Valle, Juan W
Voi, M
Pacaud, L
Lincy, J
Okita, N
Citations
Altmetric:
Abstract
Description
Date
2017
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Everolimus for advanced, progressive, nonfunctional neuroendocrine tumors (NET) of the gastrointestinal (GI) tract: efficacy and safety from a RADIANT-4 subgroup analysis. 2017, 46(3): 436-436 Pancreas